CLEOPATRA: A multicentre phase III randomised controlled single masked clinical trial

New funded grant by UMS member: Professor Toby Prevost

2014-2017       CLEOPATRA: A multicentre phase III randomised controlled single masked clinical trial to test the clinical efficacy of LightMasks at preventing dark adaptation in the treatment of early diabetic macular oedema.

PI: S. Sivaprasad (KCH and Moorfields). NIHR EME 11_30_02 £1.1M. (42 months).

http://www.nets.nihr.ac.uk/projects/eme/113002

Advertisements